ALX2004 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19 results for “ALX2004”

Trials

View all 12 →

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

170 participants · First posted Jul 25, 2025

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

235 participants · First posted Aug 7, 2025

TDM of Asparaginase in ALL2008

765 participants · First posted Apr 13, 2021

Drugs

APX2014

APX2044

Investigational

LX2006

News

ALX Oncology Appoints Barbara Klencke as Interim Chief Medical Officer to Advance Cancer Pipeline

Evorpacept-Keytruda Combination Fails to Meet Primary Endpoints in Head and Neck Cancer Trials

Page 1 of 2